The  logo

Medicines

  1. Long-term antipsychotic use in Alzheimer's may increase risk of death

    12 Jan 09 | 16.00 | England Scotland Wales

    Long-term antipsychotic use in patients with Alzheimer’s disease (AD) may lead to an increased risk of mortality, research published in The Lancet has shown more >

  2. PJ letters (3/10 January 2009)

    9 Jan 09 | 22.30 | England Scotland Wales

    Letters published in the 3/10 January 2009 issue of The Pharmaceutical Journal

    more >

  3. American Society of Health-System Pharmacists midyear (2008) meeting

    9 Jan 09 | 17.52 | International

    The importance of reconciling medicines with indications, a novel approach to pharmacy marketing and an alternative use for Vaseline were discussed at the ASHP’s midyear (2008) clinical meeting

    more >

  4. Risk of serious errors with piperacillin/tazobactam highlighted in Drug Safety Update

    9 Jan 09 | 15.52 | England Scotland Wales

    Clearer labelling of reconstituted generic piperacillin/tazobactam products has been called for because of the risk of serious medication errors due to differing compatibility of generic piperacillin/tazobactam products with other medicines compared with the brand leader Tazocin more >

  5. New rules mean athletes can declare non-systemic glucocorticosteroid use online

    9 Jan 09 | 15.47 | England Scotland Wales

    Athletes are no longer required to apply for approval to use non-systemic glucocorticosteroids, but can declare that they are using the prohibited substances in a new scheme being launched by UK Sport more >

  6. New anticoagulants reviewed at US event

    9 Jan 09 | 15.46 | International

    There are good data to support using rivaroxaban to prevent deep vein thrombosis and promising results for using it to treat venous thromboembolism (VTE). However, there is currently insufficient evidence to recommend rivaroxaban for thromboprophylaxis in patients with atrial fibrillation

    more >

  7. Depression with Parkinson’s disease responds better to TCA than SSRI

    9 Jan 09 | 15.46 | International

    Parkinson’s disease (PD) patients with depression may respond better to tricyclic antidepressants (TCAs) than to the widely prescribed selective serotonin reuptake inhibitors (SSRIs), according to the results of a study published online

    more >

  8. Antidepressant use in Scotland increases

    9 Jan 09 | 15.45 | Scotland

    Prescribing of antidepressants rose in NHS Scotland by 4.7 per cent between 2006–07 and 2007–08, according to official figures more >

  9. Genetics could affect response to clopidogrel

    9 Jan 09 | 15.45 | International

    The clinical effectiveness of clopidogrel in the treatment of cardiovascular disease may be affected by patients’ genetic make-up, according to two studies published online

    more >

  10. Fish oil supplements reviewed

    9 Jan 09 | 15.44 | International

    Use of fish oil supplements is associated with reduced death from cardiac causes but has no effect on arrhythmias or all-cause mortality, a meta-analysis published online indicates

    more >